Rapid Tests Market

Increase in awareness of rapid tests played a major role in the growth of the rapid tests market.

NE WIN SIVERS DRIVE, PROVINCE: - PORTLAND, UNITED STATES, December 9, 2021 /EINPresswire.com/ -- According to the report published by Allied Market Research, the global rapid tests market was estimated at $23.41 billion in 2017 and is expected to hit $39.10 billion by 2023, growing at a CAGR of 8.9% from 2017 to 2023. The report offers an in-depth analysis of the market, covering aspects such as top investment pockets, drivers, restraints, & opportunities, major market segments, strategic developments, and competitive landscape.

Benefits of rapid tests over laboratory testing, increase in initiatives of government & nonprofit organizations toward health awareness, and rise in healthcare expenditure worldwide have fueled the growth of the global rapid tests market. On the other hand, inadequate reimbursement policies for rapid test diagnostics hampers the growth to certain extent. Nevertheless, growth opportunities in the emerging markets and increase in prevalence of various chronic as well as infectious diseases across the world have created multiple opportunities in the segment.

𝗚𝗲𝘁 𝗣𝗗𝗙 𝗕𝗿𝗼𝗰𝗵𝘂𝗿𝗲 𝗢𝗳 𝗧𝗵𝗶𝘀 𝗥𝗲𝗽𝗼𝗿𝘁 𝗪𝗶𝘁𝗵 𝗗𝗲𝘁𝗮𝗶𝗹𝗲𝗱 𝗔𝗻𝗮𝗹𝘆𝘀𝗶𝘀 @ https://www.alliedmarketresearch.com/request-sample/4633

𝗖𝗼𝗺𝗽𝗿𝗲𝗵𝗲𝗻𝘀𝗶𝘃𝗲 𝗰𝗼𝗺𝗽𝗲𝘁𝗶𝘁𝗶𝘃𝗲 𝗮𝗻𝗮𝗹𝘆𝘀𝗶𝘀 𝗮𝗻𝗱 𝗽𝗿𝗼𝗳𝗶𝗹𝗲𝘀 𝗼𝗳 𝗺𝗮𝗷𝗼𝗿 𝗺𝗮𝗿𝗸𝗲𝘁 𝗽𝗹𝗮𝘆𝗲𝗿𝘀, 𝘀𝘂𝗰𝗵 𝗮𝘀

Akers Biosciences, Inc., Alere Inc. (Abbott Laboratories), Becton, Dickinson and Company, Bio-rad Laboratories, Inc., Cepheid, Inc., Hologic, Inc., Meridian Bioscience, Inc., OraSure Technologies, Inc., Quidel Corporation, and Roche Diagnostics.

😷 𝗖𝗼𝘃𝗶𝗱-𝟭𝟵 𝗦𝗰𝗲𝗻𝗮𝗿𝗶𝗼:

1) The Covid-19 pandemic and followed by lockdown has affected several manufacturing industries.
2) The prolonged lockdown resulted in a disrupted supply chain and increased the prices of raw materials.
3) However, as the world has been recovering from the pandemic, the market is estimated to get back on track.

𝗚𝗲𝘁 𝗗𝗲𝘁𝗮𝗶𝗹𝗲𝗱 𝗖𝗼𝘃𝗶𝗱-𝟭𝟵 𝗜𝗺𝗽𝗮𝗰𝘁 𝗔𝗻𝗮𝗹𝘆𝘀𝗶𝘀 𝗮𝘁: https://www.alliedmarketresearch.com/request-for-customization/4633?reqfor=covid

The OTC segment to rule the roost-

Based on product type, the over-the-counter (OTC) rapid test product segment is projected to grow at the fastest CAGR of 9.2% during the study period. On the other hand, the professional rapid test products segment accounted for more than three-fifths of the total market in 2017 and is projected to retain its top status during the forecast period.

The glucose monitoring segment to dominate through 2017–2023-

Based on application, the glucose monitoring segment contributed to nearly half of the global market share in 2017 and is anticipated to dominate throughout the forecast period. On the other hand, the infectious disease segment has exhibited the fastest growth rate with a CAGR of 11.6% during the study period.

The home care segment to maintain its lion’s share till 2023-

Based on end user, the home care segment held the largest share, garnering nearly two-fifths of the total market. Simultaneously, the hospitals & clinics segment region is expected to grow at the highest CAGR of 9.5% during the forecast period.

𝐈𝐧𝐭𝐞𝐫𝐞𝐬𝐭𝐞𝐝 𝐢𝐧 𝐏𝐫𝐨𝐜𝐮𝐫𝐢𝐧𝐠 𝐭𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭? 𝐕𝐢𝐬𝐢𝐭 𝐇𝐞𝐫𝐞: https://www.alliedmarketresearch.com/purchase-enquiry/4633

𝗔𝘃𝗲𝗻𝘂𝗲 𝗕𝗮𝘀𝗶𝗰 𝗣𝗹𝗮𝗻 | 𝗟𝗶𝗯𝗿𝗮𝗿𝘆 𝗔𝗰𝗰𝗲𝘀𝘀 | 𝟭 𝗬𝗲𝗮𝗿 𝗦𝘂𝗯𝘀𝗰𝗿𝗶𝗽𝘁𝗶𝗼𝗻 |

Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.

Request for 14 days free trial: https://www.alliedmarketresearch.com/avenue/trial/starter

“We have also published few syndicated market studies in the similar area that might be of your interest. Below are the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market.”

𝗧𝗿𝗲𝗻𝗱𝗶𝗻𝗴 𝗥𝗲𝗽𝗼𝗿𝘁𝘀 𝗶𝗻 𝗛𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 𝗜𝗻𝗱𝘂𝘀𝘁𝗿𝘆 (𝗕𝗼𝗼𝗸 𝗡𝗼𝘄 𝘄𝗶𝘁𝗵 𝟭𝟬% 𝗗𝗶𝘀𝗰𝗼𝘂𝗻𝘁):

Next Generation Sequencing Market – Opportunity & Industry Forecast, 2030
Telemedicine market – Opportunity & Industry Forecast, 2030

𝐀𝐛𝐨𝐮𝐭 𝐔𝐬

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

David Correa
Allied Analytics LLP
+1 503-894-6022
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.